ARX

NEUTRALM&A

ARX

Price
$19.77
-0.15%

This is the 2026-10-12 snapshot — the signals and analysis for ARX as of this single trading day.

View full ARX research hub →
Score10.5Top Tier
Signals6/8 DNA1/13 Act · 0/4 Risk
SentimentNEUTRALScore: 0
Volume0.4xvs 20d avg

Analysis

The 'Why' behind ARX's stagnant price action is its pending take-private acquisition by Thoma Bravo, which has pinned the stock following the recent expiration of its 'go-shop' period. This M&A dynamic perfectly explains the extreme technical compression—highlighted by a BOLLINGER_SQUEEZE, a QUIET_STORM signal, and an ultra-low 4.2% realized volatility—as institutional arbitrageurs lock in the deal spread. Furthermore, the broader RISK_ON macro regime and exceptionally tight credit spreads (0.82%) provide high conviction that private equity financing remains frictionless, allowing the market to confidently ignore recent analyst downgrades and insider selling as mechanical noise.

Fired Signals

ALPHA MALEQUIET STORMGOLDEN CROSSBOLLINGER SQUEEZEMARKET LEADERPERFECT STACKSELLER FATIGUE

Key Takeaways

  • Actionable Thesis: ARX is a pure merger arbitrage play; the BOLLINGER_SQUEEZE and low volume reflect institutional pinning near the Thoma Bravo deal price following the go-shop expiration.
  • Key Risk: The primary risk is deal collapse due to regulatory hurdles or unexpected financing issues, which would break the extreme technical compression.
  • What to Watch: Monitor the $19.66 line-in-the-sand as a proxy for arbitrage support, alongside any antitrust or regulatory filings ahead of the 1H 2027 expected close.
© 2026 Signal52 • For educational purposes only